Tobacco used to create cancer vaccine

A new cancer vaccine made from genetically engineered tobacco leaves has been found safe in a small, early-stage trial. The vaccine also spurred the immune systems of 11 out of 16 volunteers in the trial to attack non-Hodgkin's lymphoma, setting it up for a larger trial to help determine whether the therapy should become a key supplement to chemotherapy. FierceVaccines

Suggested Articles

Levo Therapeutics’ lead program did not beat placebo in a phase 3 study of Prader-Willi syndrome, a genetic disorder that causes insatiable hunger.

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.